References
- Allison AC, Gregoriadis G. Liposomes as immunological adjuvants. Nature 1974; 252: 252
- Alving CR. Liposomes as carriers of antigens and adjuvants. Immunol Methods 1991; 140: 1–13
- Bangham AD, Standish MM, Weismann G. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–252
- Barenholz Y. Liposome technology. G Gregoriadis. Informa, New York 2007; II: 1–25
- Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990; 1029: 91–97
- Cevc G, Vierl U. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. J Control Release 2007; 118: 18–26
- Gregoriadis G. Drug entrapment in liposomes. FEBS Lett 1973; 36: 292–296
- Gregoriadis G. Structural requirements for the specific uptake of macromolecules and liposomes by target tissues. Enzyme therapy in lysosomal storage disease, JM Tager, GJM Hooghwinkel, WTh Deams. North-Holland Publishing Co., Amsterdam 1974; 131–148
- Gregoriadis G. The carrier potential of liposomes. New Engl J Med 1976; 295: 765–770
- Gregoriadis G. Liposomes technology. CRC Press, Boca Raton 1992; I-III
- Gregoriadis G. Twinkling guide stars to throngs of acolytes desirous of your membrane semi-barriers, precursors of bion, potential drug carriers. J Liposome Res 1995; 5: 329–346
- Gregoriadis G. Liposome technology3rd. Informa, New York 2007
- Gregoriadis G, Allison AC. Entrapment of proteins in liposomes prevents allergic reactions in preimmunised mice. FEBS Lett 1974; 45: 71–74
- Gregoriadis G, Bacon A, McCormack B, Laing P, Frisch B, Schuber F. Liposome-based DNA/protein vaccines: Procedures for entrapment and immunization studies. G Gregoriadis. Informa, New York 2007; II: 233–244, editor. Liposome technology. 3rd ed.
- Gregoriadis G, Buckland RA. Enzyme-containing liposomes alleviate a model for storage disease. Nature 1973; 244: 170–172
- Gregoriadis G, Neerunjun DE. Treatment of tumour bearing mice with liposome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol 1975a; 10: 351–362
- Gregoriadis G, Neerunjun ED. Homing of liposomes to target cells. Biochem Biophys Res Commun 1975b; 65: 537–544
- Gregoriadis G, Ryman BE. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage disease. Eur J Biochem 1972a; 24: 485–491
- Gregoriadis G, Ryman BE. Lysosomal localization of β-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders. Biochem J 1972b; 129: 123
- Gregoriadis G, Senior J. The phospholipid component of small liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett 1980; 119: 43–46
- Gregoriadis G, Morell AG, Sternlieb I, Scheinberg IH. Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem 1970; 245: 5833–5837
- Gregoriadis G, Leathwood PD, Ryman BE. Enzyme entrapment in liposomes. FEBS Lett 1971; 14: 95
- Gregoriadis G, Swain CP, Wills EJ, Tavill AS. Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1974; i: 1313–1316
- Gregoriadis G, Saffie R, de Souza B. Liposome-mediated DNA vaccination. FEBS Lett 1997; 402: 107–110
- Hwang KJ, Luke KFS, Baumier PL. Hepatic uptake and degradation of unilamellar sphingo-myelin/cholesterol liposomes: A kinetic study. Proc Natl Acad Sci USA 1980; 77: 4030–4034
- Juliano R, Stamp D. Effect of particle size and charge on the clearance of liposome-encapsulated drugs. Biochem Biophys Res Commun 1975; 63: 651–658
- Kirby C, Clarke J, Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980; 186: 591–598
- Klibanov AL, Marnyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990; 268: 235–237
- Leserman L. Liposomes as protein carriers in immunology. J Liposome Res 2004; 14: 175–189
- Morell A, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246: 1461–1467
- O'Neil GJ. The use of antibodies as drug carriers. Drug carriers in biology and medicine, G Gregoriadis. Academic Press, London 1979; 23–41
- Papahadjopoulos D. Liposomes and their uses in biology and medicine. NY Acad Sci 1978; 308: 1–462
- Papahadjopoulos D, Allen T, Gabizon A, Mayhew E, Matthay K, Huang K, Lee SK, Woodle MC, Lasic DD, Redemann C, Martin FJ. Sterically stabilized liposomes: Improvements in pharmacokinetics, tissue disposition and anti-tumour therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11460–11464
- Perrie Y, Frederik PM, Gregoriadis G. Liposome-mediated DNA vaccination: The effect of vesicle composition. Vaccine 2001; 19: 3301–3310
- Senior JH, Gregoriadis G. Is half-life of circulating small unilamellar liposomes determined by changes in their permeability?. FEBS Lett 1982; 145: 109–114
- Senior JH, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: Studies with polyethylene glycol-coated vesicles. Biochim Biophys Acta 1991; 1062: 77–82